Interestingly, genetic deletion of Bach1 and pharmacological inhibition by the newly identified non-electrophilic inhibitor (HPPE) significantly attenuated these pathological PD hallmarks in the PFF-injected PD mice. This evidence concerns the gene BACH1 and Parkinson disease.